These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32125401)

  • 1. Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies.
    Ledley FD; McCoy SS; Vaughan G; Cleary EG
    JAMA; 2020 Mar; 323(9):834-843. PubMed ID: 32125401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study.
    Meyers DE; Meyers BS; Chisamore TM; Wright K; Gyawali B; Prasad V; Sullivan R; Booth CM
    Cancer; 2022 Jan; 128(2):311-316. PubMed ID: 34614198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profit pools: a fresh look at strategy.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 1998; 76(3):139-47. PubMed ID: 10179649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to map your industry's profit pool.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 1998; 76(3):149-52, 154, 156 passim. PubMed ID: 10179650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of capital structure on the profitability of pharmaceutical companies the case of iran.
    Mohammadzadeh M; Rahimi F; Rahimi F; Aarabi SM; Salamzadeh J
    Iran J Pharm Res; 2013; 12(3):573-7. PubMed ID: 24250664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dataset of companies' profitability, government debt, financial statements' key indicators and earnings in an emerging market: Developing a panel and time series database of value-added tax rate increase impacts.
    Mgammal M; Al-Matari E
    F1000Res; 2023; 12():405. PubMed ID: 38434636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profitability analysis in the hospital industry.
    Cleverley WO
    Health Serv Res; 1978; 13(1):16-27. PubMed ID: 632101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.
    Tay-Teo K; Ilbawi A; Hill SR
    JAMA Netw Open; 2019 Jan; 2(1):e186875. PubMed ID: 30644967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-profit Drug Research and Development at a Crossroads.
    Jarosławski S; Toumi M; Auquier P; Dussart C
    Pharm Res; 2018 Feb; 35(3):52. PubMed ID: 29417233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hospital conversions to for-profit status and clinical and economic outcomes.
    Joynt KE; Orav EJ; Jha AK
    JAMA; 2014 Oct 22-29; 312(16):1644-52. PubMed ID: 25335146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical care medicine as a distinct product line with substantial financial profitability: the role of business planning.
    Bekes CE; Dellinger RP; Brooks D; Edmondson R; Olivia CT; Parrillo JE
    Crit Care Med; 2004 May; 32(5):1207-14. PubMed ID: 15190974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of working capital management for hospital profitability: evidence from bond-issuing, not-for-profit U.S. hospitals.
    Rauscher S; Wheeler JR
    Health Care Manage Rev; 2012; 37(4):339-46. PubMed ID: 21712724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-time correlations in company profit fluctuations: presence of extreme events.
    Roman HE; Siliprandi RA; Dose C; Porto M
    Phys Rev E Stat Nonlin Soft Matter Phys; 2009 Sep; 80(3 Pt 2):036114. PubMed ID: 19905187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring payments in the US pharmaceutical market from 2011 to 2019: Update on pharmacy benefit manager impact.
    Weinstein EP; Schulman K
    Am Heart J; 2020 Sep; 227():107-110. PubMed ID: 32730906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of revenue and cost-management strategies of not-for-profit and for-profit hospitals.
    Shukla RK; Pestian J; Clement J
    Hosp Health Serv Adm; 1997; 42(1):117-34. PubMed ID: 10164894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not-for-profit not equal to no profit: profitability planning in not-for-profit organizations.
    Fallon RP
    Health Care Manage Rev; 1991; 16(3):47-61. PubMed ID: 1938390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States' Nursing Home Finances: Spending, Profitability, and Capital Structure.
    Harrington C; Mollot R; Braun RT; Williams D
    Int J Soc Determinants Health Health Serv; 2024 Apr; 54(2):131-142. PubMed ID: 38115716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.